These data suggest a revision of the original ADAPT hypothesis that NSAIDs reduce AD risk , as follows : NSAIDs have an adverse effect in later stages of AD pathogenesis , whereas asymptomatic individuals treated with conventional NSAIDs such as naproxen experience reduced AD incidence , but only after 2 to 3 years .
